top of page
Recombinant Human Serum Albumin (plant-derived)

Recombinant Human Serum Albumin (plant-derived)

SKU: oryzogen-HYC002M01
65,00 €Price
Quantity
  • Recombinant Human Serum Albumin (plant-derived)

    Download datasheet

    Download MSDS

     

    Alternate Names

    Serum Albumin, HSA

    Characteristics

    Species

    Human

    Expression System

    Rice Grain (Oryza Sativa)

    Fusion Tag

    Tag Free

    Molecular Weight

    66.5 kDa

    Specification

    Appearance

    Light yellow to white or greyish-white powder or crystalline powder

    Purity

    99%, by SDS-PAGE

    Endotoxin Level

    <0.125 EU/mg

    Formulation

    Lyophilized powder

    Size

    1g, 10g, 50g and 100g

    Handling and Storage

    Reconstitution

    Recommend to reconstitute in the sterile PBS. Further dilutions can be made in other aqueous buffer.

    Shipping

    The product is shipped with blue ice.

    Storage & Stability

    Stored at temperature 2~8°C for at least 60 months. Please avoid repeated freeze-thaw cycles.

     

    In recent years, there has been an increased demand for animal-free components to replace serum or animal originated supplements to eliminate the risk of viruses and mycoplasma contaminants. Using the rice endosperm specific expression platform, the OsrHSA Advanced, which is animal component free, can provide an economical and safe approach for the production of non–animal-derived compounds.

     

    Human plasma is also in limited supply. Rice as bioreactor show great promise as a flexible system for the production and processing of OsrHSA Advanced with intact biochemical features on a large scale. The rice endosperm specific expression platform is easy to be large-scale, because the rice endosperm has the protein body, which can keeps proteins stability and bioactivity. At present, the production capacity of OsrHSA is almost tons a year.

     

    The OsrHSA Advanced is animal component free and has very good batch consistency, which has many advantages. These include:

    01/ elimination or reduction of the potential risk of viruses and mycoplasma contaminants in blood derived products;

    02/ void the impact of serum components in the experimental study;

    03/ well-defined component;

    04/ simplify the downstream bio-processing or biological research;

    05/ stable supply and no dependence on a process based on fractionation from precious donated blood;

    06/ very good batch consistency and avoid the batch difference.

     

LF-Biotech GmbH
Dr.-Adenauer-Ring 26
55288 Schornsheim
Germany

contact@LF-Biotech.com

+49-17699949261

Amtsgericht Mainz, HRB 52858

VAT identification number: DE367697334

IBAN: DE64 1001 8000 0648 6109 31

©2025 by LF-Biotech.com. Proudly created with Wix.com

bottom of page